Search

Feb 20 // Product Innovation Winner at Congrès de l'Encéphale 2020 (France's Brain Congress).

​February 2020 //

Taliaz selected by Deloitte as one of Digitial Trials - Israeli Startups at the forefront of the Digital R&D Revolution.

Very proud to announce our #PREDICTIX technology to reduce the trial and error process in prescribing psychiatric treatments won France's prestigious 2020 Brain Congress Startup Competition! Congrès de l'Encéphale is a benchmark event in the psychiatry field in France bringing together more than 4000 psychiatric experts.








CONTACT US

Tel: +972 (0)77 335 2506

Fax: +972 (0)3 650 5594

office@taliazhealth.com

2 Prof. Yehezkel Kaufmann St.

(15th Floor), Tel Aviv-Yafo, Israel

  • LinkedIn
  • Twitter
  • Facebook
PREDICTIX_Logo_Dark.png

Disclaimer: Taliaz is developing the PREDICTIX Genetics and PREDICTIX Digital products. PREDICTIX Genetics Antidepressant and PREDICTIX Digital Antidepressant are currently available for commercial use in the EU and Israel. Outside of the EU and Israel, PREDICTIX Genetics & Digital products are currently limited by law for investigational use only.

Copyright © 2020 PREDICTIX by TALIAZ Ltd. All Rights Reserved